Top 100 medical and healthcare startups in Israel
Dec 07, 2025
|
Like
18
1
Funding: $1B
Novocure is developing a new treatment for solid tumors known as tumor polytherapy (TTFields). TTFields are low-intensity alternating electric fields, particularly at intermediate frequencies that disrupt cancer cell division through physical interaction with key molecules during mitosis. TTFields do significantly affect healthy cells, as they have different properties (including division rate, morphology and electrical properties) compared to cancer cells. The company's TTFields pipeline includes therapies against glioblastoma, metastatic non-small cell lung cancer and pancreatic cancer. The company also produces FDA-approved portable devices for the treatment of GB and mNSCLC. These devices also work via creating electric fields that can slow or stop cancer cell division.
Novocure is developing a new treatment for solid tumors known as tumor polytherapy (TTFields). TTFields are low-intensity alternating electric fields, particularly at intermediate frequencies that disrupt cancer cell division through physical interaction with key molecules during mitosis. TTFields do significantly affect healthy cells, as they have different properties (including division rate, morphology and electrical properties) compared to cancer cells. The company's TTFields pipeline includes therapies against glioblastoma, metastatic non-small cell lung cancer and pancreatic cancer. The company also produces FDA-approved portable devices for the treatment of GB and mNSCLC. These devices also work via creating electric fields that can slow or stop cancer cell division.
2
Funding: $414M
AIdoc helps radiologists work through their case load faster, just in time to make a difference. We reworked deep learning algorithms to analyze imaging and clinical data more effectively, and can produce highly accurate scan anomaly detection. We combine the analyzed scans with patient data, streamlining the radiologists' workflow and freeing them to do what they do best.
AIdoc helps radiologists work through their case load faster, just in time to make a difference. We reworked deep learning algorithms to analyze imaging and clinical data more effectively, and can produce highly accurate scan anomaly detection. We combine the analyzed scans with patient data, streamlining the radiologists' workflow and freeing them to do what they do best.
3
Funding: $274M
Nanox Medical researches and develops breakthrough X-ray technology that generates unique monochromatic X-rays with very high fluency.
Nanox Medical researches and develops breakthrough X-ray technology that generates unique monochromatic X-rays with very high fluency.
4
Funding: $226.3M
Carbyne is a national emergency communication platform, running the most advanced technology for emergency infrastructure.
Carbyne is a national emergency communication platform, running the most advanced technology for emergency infrastructure.
5
Funding: $225.6M
Augmedics develops cutting-edge technologies for future surgery. Augmedics develops a smart surgical system - The ViZOR: An Augmented Reality Head Mounted Display equipped with various sensors and machine learning capabilities, to be the enabling technology for future surgery.
Augmedics develops cutting-edge technologies for future surgery. Augmedics develops a smart surgical system - The ViZOR: An Augmented Reality Head Mounted Display equipped with various sensors and machine learning capabilities, to be the enabling technology for future surgery.
6
Funding: $218.2M
ReWalk Robotics is an innovative medical device company that is designing, developing and commercializing exoskeletons allowing wheelchair-bound individuals to stand and walk once again. Our mission is to fundamentally change the Quality of Life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
ReWalk Robotics is an innovative medical device company that is designing, developing and commercializing exoskeletons allowing wheelchair-bound individuals to stand and walk once again. Our mission is to fundamentally change the Quality of Life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
7
Funding: $205.7M
A disruptive mobile-health AI-powered platform and device, allowing anyone to perform self physical examination and remote diagnosis.
A disruptive mobile-health AI-powered platform and device, allowing anyone to perform self physical examination and remote diagnosis.
8
Funding: $190M
ForSight Robotics created surgical platform designed specifically for ophthalmological (eye) surgeries — a category requiring a great deal of precision.
ForSight Robotics created surgical platform designed specifically for ophthalmological (eye) surgeries — a category requiring a great deal of precision.
9
Funding: $185M
Healthy.io de Dip.io, a home-based urinalysis kit that turns a smartphone into a clinical-grade diagnostic device. It’s the first smartphone-based urine test to secure clearance as a Class 2 device.
Healthy.io de Dip.io, a home-based urinalysis kit that turns a smartphone into a clinical-grade diagnostic device. It’s the first smartphone-based urine test to secure clearance as a Class 2 device.
10
Funding: $179M
Magenta Medical has developed a temporary venous catheter-based therapy for hospital-admitted patients with Acute Decompensated Heart Failure (ADHF).
Magenta Medical has developed a temporary venous catheter-based therapy for hospital-admitted patients with Acute Decompensated Heart Failure (ADHF).
11
Funding: $149.7M
LifeBeam creates headphones VI that come with incredible sound and real time fitness coaching.
LifeBeam creates headphones VI that come with incredible sound and real time fitness coaching.
12
Funding: $130M
OrCam’s mission is to harness the power of artificial vision by incorporating pioneering technology into a wearable platform which improves the lives of individuals who are blind, visually impaired, and have reading difficulties. OrCam has created a technologically advanced device unique in its ability to provide visual aid through a discreet wearable platform and simple easy-to-use interface which serves to enhance the daily lives of people with vision loss.
OrCam’s mission is to harness the power of artificial vision by incorporating pioneering technology into a wearable platform which improves the lives of individuals who are blind, visually impaired, and have reading difficulties. OrCam has created a technologically advanced device unique in its ability to provide visual aid through a discreet wearable platform and simple easy-to-use interface which serves to enhance the daily lives of people with vision loss.
13
Funding: $128M
Memic has set out to transform robotic-assisted surgery, with proprietary technology that has the potential to far surpasses today’s best solutions. Providing unprecedented access and maneuverability, our Memic’s Hominis surgical platform features miniature, humanoid-shaped robotic arms with human dexterity, superhuman flexibility, and 360˚ articulation.
Memic has set out to transform robotic-assisted surgery, with proprietary technology that has the potential to far surpasses today’s best solutions. Providing unprecedented access and maneuverability, our Memic’s Hominis surgical platform features miniature, humanoid-shaped robotic arms with human dexterity, superhuman flexibility, and 360˚ articulation.
14
Funding: $126M
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
15
Funding: $125.1M
Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology.
Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology.
16
Funding: $123.8M
Sight Diagnostics aims to bring affordable, scalable and accurate blood diagnostics to the point-of-care, thereby accelerating better patient outcomes and improving healthcare for all. Sight has developed an artificial intelligence-driven platform for blood analysis and infectious disease diagnostics based on its proprietary machine-vision technology.
Sight Diagnostics aims to bring affordable, scalable and accurate blood diagnostics to the point-of-care, thereby accelerating better patient outcomes and improving healthcare for all. Sight has developed an artificial intelligence-driven platform for blood analysis and infectious disease diagnostics based on its proprietary machine-vision technology.
17
Funding: $118.5M
Ibex is pioneering AI-based cancer diagnostics in pathology. Its Galen platform uses AI-based algorithms to analyze images, detect and grade cancer in biopsies, helping pathologists reduce diagnostic error rates and enable a more efficient workflow.
Ibex is pioneering AI-based cancer diagnostics in pathology. Its Galen platform uses AI-based algorithms to analyze images, detect and grade cancer in biopsies, helping pathologists reduce diagnostic error rates and enable a more efficient workflow.
18
Funding: $104M
MDClone offers a new heatlhcare data paradigm, enabling fast and direct access to healthcare data while fully protecting patient’s privacy.
MDClone offers a new heatlhcare data paradigm, enabling fast and direct access to healthcare data while fully protecting patient’s privacy.
19
Funding: $101.5M
KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.
KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.
20
Funding: $100M
CytoReason is an AI company developing a computational model of the human body, accurate enough to start replacing animal and human trials in drug development.
CytoReason is an AI company developing a computational model of the human body, accurate enough to start replacing animal and human trials in drug development.
